INTERCURE news, videos and press releases
For more news please use our advanced search feature.
INTERCURE - More news...
INTERCURE - More news...
- InterCure Announces First Half of 2024 Results: Revenue of NIS 126 million and Adjusted EBITDA of NIS 21 million
- InterCure Provides an Update Regarding Nir Oz Facility
- InterCure Signs Definitive Agreement to Acquire Leon Cannabis Pharmacy Chain
- InterCure Wins Cannolam Arbitration Proceeding
- InterCure Provides an Update Regarding the Security Situation in Israel
- InterCure Announces Record Revenues First Half of 2023 with over 14% growth YOY
- InterCure Ltd. Announces Proposed Voluntary Delisting from the Toronto Stock Exchange and shall continue to be listed on the NASDAQ and TASE
- InterCure Provides an Update About The Lawsuit it Filed Against Cann Pharmaceuticals to Recover Funds Following Failed Merger
- InterCure to Participate in the Cowen 3rd Annual European Cannabis Conference
- InterCure Announces Record Breaking First Quarter Revenues with 22% growth YOY
- InterCure to Be Featured with Mike Tyson in an Exclusive Interview on Fox Business
- InterCure Informs That A Lawsuit Was Filed Against the Company by Minority Shareholders of Its Subsidiary
- InterCure Informs That An Application To Approve a Class Action Against 26 Cannabis Companies in Israel, Including InterCure, Was Filed to The Court In Israel
- InterCure Ltd. Partners with TYSON 2.0 in Israel, Australia, United Kingdom, Germany and Other EU Countries
- InterCure Reschedules 2022 Full Year Results Conference Call
- InterCure Announces Record Fourth Quarter and Fiscal Year End 2022 Results
- InterCure Files Lawsuit Against Cann Pharmaceuticals to Recover Funds Following Failed Merger
- InterCure Announces the Termination of its Acquisition Agreement with Cann Pharmaceutical (dba Better)
- InterCure Announces Exclusive International Partnership Agreement with Award Winning Cannabis Brand "Binske"
- InterCure to Participate in Cowen 5th Annual Cannabis Conference
- InterCure Announces the Withdrawal of a Class Action Lawsuit against it
- Update regarding Better Transaction
- Organigram and Intercure (dba : Canndoc) Sign New International Strategic Agreement Representing Largest Such Deal to Date for Both Companies
- CORRECTION and MULTIMEDIA UPDATE -- InterCure Announces Record Breaking Third Quarter Financial Results with 63% growth YOY and 6% QoQ growth
- InterCure Announces Record Breaking Third Quarter Financial Results with 63% growth YOY and 6% QoQ growth
- InterCure Announces Record Preliminary Third Quarter Revenue of Over CAD$39 million – 63% Growth YoY
- Intercure Ltd. Announces Voting Results from its Annual and Special Meeting of Shareholders
- InterCure Reports Record Breaking Second Quarter Financial Results
- InterCure to Release its Q2 2022 Results and Hold a Conference Call
- InterCure Reports Record Preliminary 2022 Second Quarter Revenue – More Than Double YoY and 9% QoQ Growth
